⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24917350 | 0.84 | — | — | |
| SCHEMBL24917144 | 0.84 | — | — | |
| SCHEMBL24916945 | 0.75 | — | — | |
| SCHEMBL24791758 | 0.72 | TMPRSS2 (0.42) | — | |
| SCHEMBL24916961 | 0.71 | — | — | |
| SCHEMBL26546004 | 0.70 | TSHR (0.32) | — | |
| SCHEMBL24916931 | 0.69 | TMPRSS2 (0.51) | — | |
| SCHEMBL26328104 | 0.69 | EGLN2 (0.38) | — | |
| SCHEMBL30603746 | 0.69 | TMPRSS2 (0.49) | — | |
| SCHEMBL26325669 | 0.67 | EGFR (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230024722-A1 | ORALLY-BIOAVAILABLE NUCLEOSIDE ANALOGS | VenatoRx Pharmaceuticals, Inc. | 2023-01-26 | — | — | US | disclosed |